{"id":"W4396732203","doi":"10.1016/j.annonc.2024.04.013","title":"Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"ca_institutions":"Regional Municipality of Durham","funders":"Sanofi Genzyme; Gilead Sciences; Sanofi; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Nonsteroidal; Aromatase inhibitor; Aromatase; Oncology; Internal medicine; Breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001323866,0.0006741423,0.001332365,0.0003855853,0.0003237984,0.0005880077,0.0004837838,0.0005462742,0.002094601],"category_scores_gemma":[0.0006241213,0.0002536671,0.001719207,0.0002385924,0.000464741,0.0003719244,0.0003295546,0.001260161,0.0002946558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001031151,"about_ca_system_score_gemma":0.001269031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002081224,"about_ca_topic_score_gemma":0.01011051,"domain_scores_codex":[0.99967,0.0001329867,0.00002254042,0.00003616616,0.00005747578,0.00008089784],"domain_scores_gemma":[0.9995247,0.00006329078,0.0001170427,0.00006036623,0.00003575584,0.0001989425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.791838,0.01863478,0.00822526,0.0009786629,0.002586366,0.0001739159,0.0001737125,0.0016562,0.03247067,0.0002320253,0.002624074,0.1404064],"study_design_scores_gemma":[0.2724949,0.5981509,0.09896842,0.000151425,0.003757368,0.0005457963,0.0001097449,0.001309368,0.0143407,0.0003690106,0.009736944,0.00006541955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913028,0.005300864,0.0002707277,0.0002607728,0.00005923094,0.0004060011,0.0007269633,0.00004298036,0.001629589],"genre_scores_gemma":[0.9921577,0.0020264,0.0005700212,0.00049539,0.0001010896,0.0003312545,0.00140781,0.00001524287,0.002895098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002094601,"threshold_uncertainty_score":0.007481515,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1035576446243398,"score_gpt":0.4507032766043178,"score_spread":0.3471456319799779,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}